Editorial
doi: 10.1001/jama.2017.5899.
Treatment of Macular Edema Due to Central Retinal Vein Occlusion: Another Score for Repackaged Bevacizumab
Affiliations
- PMID: 28492939
- DOI: 10.1001/jama.2017.5899
Item in Clipboard
Editorial
Treatment of Macular Edema Due to Central Retinal Vein Occlusion: Another Score for Repackaged Bevacizumab
JAMA.
.
No abstract available
Comment on
-
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.JAMA. 2017 May 23;317(20):2072-2087. doi: 10.1001/jama.2017.4568. JAMA. 2017. PMID: 28492910 Free PMC article. Clinical Trial.
Similar articles
-
Central retinal vein occlusion in an otherwise healthy child treated successfully with a single injection of bevacizumab.J AAPOS. 2016 Apr;20(2):186-7. doi: 10.1016/j.jaapos.2016.01.002. Epub 2016 Mar 15. J AAPOS. 2016. PMID: 26988773 No abstract available.
-
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d. Retina. 2011. PMID: 21293319 Clinical Trial.
-
Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.Retina. 2011 Oct;31(9):1856-62. doi: 10.1097/IAE.0b013e31820d59a5. Retina. 2011. PMID: 21659943
-
Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.Retina. 2014 Dec;34(12):2439-43. doi: 10.1097/IAE.0000000000000238. Retina. 2014. PMID: 24999721
-
[Retinal vein occlusion: anti-VEGF treatments].J Fr Ophtalmol. 2009 Nov;32(9):679-86. doi: 10.1016/j.jfo.2009.10.002. Epub 2009 Oct 29. J Fr Ophtalmol. 2009. PMID: 19879018 Review. French.
Cited by
-
Monoclonal Antibodies for the Treatment of Ocular Diseases.J Clin Med. 2024 Sep 28;13(19):5815. doi: 10.3390/jcm13195815. J Clin Med. 2024. PMID: 39407875 Free PMC article. Review.
-
Prognostic Factor Study of Macular Edema Recurrence in Retinal Vein Occlusion after Conbercept Treatment: A Post Hoc Analysis of the FALCON Study.Comput Math Methods Med. 2022 Jul 29;2022:3616044. doi: 10.1155/2022/3616044. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Dec 6;2023:9858407. doi: 10.1155/2023/9858407 PMID: 35936375 Free PMC article. Retracted.
-
[Statement of the Professional Association of Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on intravitreal treatment of vision-reducing macular edema by retinal vein occlusion : Treatment strategies, status 24 April 2018].Ophthalmologe. 2018 Oct;115(10):842-854. doi: 10.1007/s00347-018-0775-0. Ophthalmologe. 2018. PMID: 30143857 Review. German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
